Arbutus Biopharma Corp (NASDAQ:ABUS)
| 3.83 Delayed Data As of 4:04pm ET |  -0.18 / -4.49%Today’s Change | 0.88 Today|||52-Week Range 9.02 | +7.89% Year-to-Date |
Latest ABUS News | Press Releases
No recent news for Arbutus Biopharma Corp.
Today’s Trading
| Previous close | 4.01 |
| Today’s open | 3.98 |
| Day’s range | 3.78 - 4.01 |
| Volume | 134,618 |
| Average volume (3 months) | 2,803,589 |
| Market cap | $343.9M |
Data as of 4:04pm ET, 01/26/2021
Growth & Valuation
| Earnings growth (last year) | -137.84% |
| Earnings growth (this year) | +66.09% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +1.11% |
| P/E ratio | NM |
| Price/Sales | 26.40 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CNCEConcert Pharmaceutic... | -0.52 | -4.68% |
| MEIPMEI Pharma Inc | -0.03 | -0.98% |
| EIGREiger BioPharmaceuti... | -0.18 | -1.69% |
| FBIOFortress Biotech Inc | -0.21 | -5.92% |
Data as of 3:59pm ET, 01/26/2021
Financials
| Next reporting date | March 11, 2021 |
| EPS forecast (this quarter) | -$0.22 |
| Annual revenue (last year) | $6.0M |
| Annual profit (last year) | -$153.7M |
| Net profit margin | -2,557.36% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Warminster, Pennsylvania |
Forecasts
